Medical reasons why cycloserine is not recommended and potential risks

Cycloserine (Cycloserine) is an anti-tuberculosis drug mainly used to treat multi-drug-resistant tuberculosis (MDR-TB) and other tuberculosis infections that are refractory to first-line drugs. Despite its remarkable efficacy, there are certain medication restrictions and contraindications due to cycloserine's pharmacological properties and potential side effects. This article will elaborate on the medical basis and potential risks of not recommending taking cycloserine, and help patients and medical staff reasonably evaluate the risks of medication.

1. The mechanism of action and scope of application of cycloserine

Cycloserine is a broad-spectrum antibiotic with a structure similar to amino acids that works by inhibiting bacterial cell wall synthesis. It has strong bactericidal activity against Mycobacterium tuberculosis and is particularly suitable for use in the treatment of drug-resistant tuberculosis. However, due to its strong toxicity to the nervous system, cycloserine needs to be used with caution in clinical use and strictly follow medical advice to avoid unnecessary risks.

2. Medical basis not recommended for use

1. Patients with mental illness should use with caution

Cycloserine can penetrate the blood-brain barrier and have a significant impact on the central nervous system. Common neuropsychiatric side effects include headache, insomnia, anxiety, depression, confusion and even epileptic seizures. Therefore, patients with a history of mental illness (such as depression, schizophrenia, epilepsy, etc.) are not recommended to use cycloserine to avoid inducing or aggravating mental symptoms.

2.Use with caution in patients with liver and kidney dysfunction

The metabolism and excretion of cycloserine mainly depends on the liver and kidneys. Patients with abnormal liver and kidney function have an increased risk of drug accumulation in the body and can easily cause toxic reactions. For patients with severe hepatic and renal insufficiency, taking cycloserine may lead to drug accumulation and trigger toxic side effects on the nervous system and other systems. Therefore, it is necessary to avoid or strictly adjust the dose.

3. Pregnant and lactating women are prohibited from use or should use with caution

At present, the safety of cycloserine on the fetus has not been fully clarified, and the drug may be secreted through breast milk and affect the baby. Pregnant women, especially those in the first trimester, should avoid the use of cycloserine to reduce the risk of fetal malformations and other adverse pregnancy outcomes. Breastfeeding women should also weigh the pros and cons when using it and make careful decisions under the guidance of a doctor.

4.Contraindicated for patients with a history of epilepsy

Cycloserine may induce seizures, particularly in patients with a history of epilepsy or seizures. This drug should be avoided in such patients to prevent serious neurological side effects.

3. Potential risks of cycloserine

1.Neuropsychiatric toxicity

The most significant side effect of cycloserine is central nervous system toxicity, including anxiety, depression, confusion, hallucinations, epileptic seizures, and disturbance of consciousness. The occurrence of these side effects is dose-related, and the risk increases significantly when taking high doses or when the drug concentration in the body is too high.

2.Allergic reaction

A small number of patients may experience allergic reactions to cycloserine, including rash, itching, difficulty breathing, etc. The drug should be discontinued in time and appropriate treatment should be taken.

3.Other system reactions

Cycloserine may also cause gastrointestinal discomfort (nausea, vomiting, diarrhea), abnormal liver function, etc. It is necessary to regularly monitor relevant indicators to detect and deal with adverse reactions in a timely manner.

4. Reasonable use and risk management

In order to reduce the risk of adverse reactions of cycloserine, applicable patients should be strictly screened clinically, and those with mental illness, history of epilepsy, and severe liver and kidney dysfunction should be excluded. Mental status assessment, liver and kidney function tests, and blood drug concentration monitoring should be carried out regularly during medication. If abnormalities are found, the dose should be adjusted or the medication should be discontinued promptly. At the same time, patients and their families need to strengthen medication safety education, pay attention to possible mental and nervous system abnormalities, and report to doctors in a timely manner.

In summary, although cycloserine plays an important role in the treatment of tuberculosis, it is not suitable for use in all patients due to its potential neuropsychiatric toxicity and other risks. Properly assessing the patient's medical history and physical condition, scientifically formulating a medication plan, and strengthening monitoring and management are the keys to ensuring the safety and effectiveness of treatment. Doctors and patients should work closely together to maximize treatment effects while reducing the occurrence of adverse events.

Reference:https://en.wikipedia.org/wiki/Cycloserine